Non-Surgical Heart Valve Replacement

Thanks to the new technologies and developed procedures in the field of Interventional Cardiology, the treatment of heart valve diseases can be done with interventional methods. Non-surgical Heart Valve Replacement can be performed with the TAVI method, which is considered revolutionary in cardiology. With this method, valve replacement is provided without opening the thorax.

The aortic valve is the valve at the mouth of the main artery leaving the heart. If you have been diagnosed with aortic stenosis, you may feel overwhelmed and it may make it difficult to seek treatment. But the sooner you take care of it, the sooner you'll be able to get back to life and everything you love.


MİTRACLIP (Non-Surgical Mitral Valve Insufficiency Repair)

With the LATCHING method, heart valve leakage is repaired without opening the thorax.

Although very clear criteria are not clear in mitraclip, there should be advanced mitral regurgitation. The cause of mitral regurgitation should not be rheumatic heart disease. Such covers are chalky, such operations cannot be successful. Today, mitraclip is mostly used in mitral regurgitation accompanied by heart failure. It can also be used in patients with mitral valve prolapse. However, the most important treatment method is still surgery.

The standard treatment method is mitral valve repair. This is done with heart surgery. Mitraclip is a somewhat experimental method at this stage. Mitraclip is the name of the device. This is a small latch-like device. The mitral valve consists of anterior and posterior leaves. With the angiography method, the heart is reached by entering the inguinal vein with a catheter and passing through the large vein in the abdomen. At this time, local anesthesia is applied to the patient in the groin. Afterwards, the mitraclip device is delivered to the level of the mitral valve through the catheter in the vein. The mitraclip's wings unfold when it reaches this point. The problematic mitral valve parts are taken under the mitral flaps, the suture loops are released, and the sutures are fixed to each other when the targeted valve structure is achieved. At this point, it is tested that sufficient closure is provided in the cover. In this way, the cover is repaired.



ASD (Atrial Septal Defect)

ASD (Atrial Septal Defect) is the most common congenital (congenital) structural heart disease in adults. Although the cause is not known exactly, it is thought that genetic and environmental conditions may be effective. It is defined as the condition of having a hole (defect) between the atria of the heart. The fact that ASD usually does not cause any symptoms causes the diagnosis of the disease to be made later. In ASD, blood flow shifts from left to right, causing increased blood flow to the lungs. Increased blood flow over the years leads to an increase in pulmonary vessel pressure. If not detected early, it can cause irreversible damage to the lungs in the future. For example, increased lung pressure can force the right side of the heart to first expand and then lead to heart failure. ASD diameter is important in the formation of these complaints. For example, defects smaller than 10 mm cause fewer complaints, while larger defects cause early findings.

The most common findings in patients are as follows:

- Palpitations, shortness of breath, fatigue,

- In addition, fainting, sometimes paralysis (loss of strength in arms and legs, vision problems, speech disorders, etc.), headache, signs of heart failure can be seen.

Diagnosis: It is made by echocardiography (Transthoracic and Transesophageal echocardiography (echocardiography procedure performed by entering the esophagus).

Treatment: It is applied in two ways.

1-The process of closing the hole with a special device by entering the groin area with the umbrella method without surgery. The process takes about half an hour. The patient is discharged one day later.

2- Surgery; If the defect diameter of the patient is too large and not suitable for the umbrella method, the patient is treated with the surgical method.



Patent foramen ovale (PFO) is the name for a small opening in our heart. Before birth, there is a transition between the two atria of the heart that is necessary for life. Immediately after birth, this transition decreases and a small transition remains in the chamber separating the two auricles and is found in almost all newborn babies. While this opening is largely closed in the first two years of life, it remains open in approximately one quarter of people. Through this opening, clean blood flows from the left atrium of the heart to the right atrium. However, since this transition is very small, it does not pose a health problem. Studies have reported that the incidence in adults varies between 20-25%. However, less than 1% have reasons that require closure.

 In the past, this closure procedure was surgically closed, but in recent years, this procedure can be performed angiographically with umbrella-like implants and has become the preferred method. The procedure is performed under local anesthesia. After the appropriate device diameter is determined by echocardiography, the umbrella is placed in the desired area by means of a long sheath placed through the inguinal vein. After the procedure, the patient can be discharged the next day. After resting at home for a few days, they can return to their daily activities. In patients who underwent closure with the closed angiographic method, it is necessary to use blood thinners for a certain period of time.


CTO (Chronic Total Occlusion)

Complete occlusion of the coronary artery for a period of at least 3 months and no blood flow from the occluded vessel.